Becker's Healthcare January 27, 2023
Paradigm, a tech company that aims to integrate clinical trials more broadly into the healthcare system, launched Jan. 27 with a $203 million series A funding round co-led by venture capital firm General Catalyst.
The startup says it’s creating a technology-enabled platform to “make clinical trials a care option for all patients.” Paradigm also acquired Deep Lens, a company that uses EHR and genomics data to recruit oncology patients for clinical trials.
“By rethinking how clinical trials are...
Today's Sponsors
Today's Sponsor